nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.102	0.598	CbGeAlD
Milnacipran—SLC6A2—autonomic nervous system—metabolic syndrome X	0.0688	0.402	CbGeAlD
Milnacipran—Contusion—Metformin—metabolic syndrome X	0.0386	0.0465	CcSEcCtD
Milnacipran—Chest discomfort—Metformin—metabolic syndrome X	0.038	0.0459	CcSEcCtD
Milnacipran—Migraine—Metformin—metabolic syndrome X	0.024	0.029	CcSEcCtD
Milnacipran—Liver function test abnormal—Metformin—metabolic syndrome X	0.0225	0.0272	CcSEcCtD
Milnacipran—Breast disorder—Metformin—metabolic syndrome X	0.0221	0.0266	CcSEcCtD
Milnacipran—Abdominal distension—Metformin—metabolic syndrome X	0.0213	0.0256	CcSEcCtD
Milnacipran—Angina pectoris—Metformin—metabolic syndrome X	0.0206	0.0248	CcSEcCtD
Milnacipran—Neutropenia—Metformin—metabolic syndrome X	0.0197	0.0238	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0196	0.0237	CcSEcCtD
Milnacipran—Hepatobiliary disease—Metformin—metabolic syndrome X	0.0178	0.0215	CcSEcCtD
Milnacipran—Hepatitis—Metformin—metabolic syndrome X	0.0169	0.0204	CcSEcCtD
Milnacipran—Hypoaesthesia—Metformin—metabolic syndrome X	0.0168	0.0203	CcSEcCtD
Milnacipran—Oedema peripheral—Metformin—metabolic syndrome X	0.0166	0.0201	CcSEcCtD
Milnacipran—Connective tissue disorder—Metformin—metabolic syndrome X	0.0166	0.02	CcSEcCtD
Milnacipran—Eye disorder—Metformin—metabolic syndrome X	0.0158	0.0191	CcSEcCtD
Milnacipran—Flushing—Metformin—metabolic syndrome X	0.0157	0.0189	CcSEcCtD
Milnacipran—Cardiac disorder—Metformin—metabolic syndrome X	0.0157	0.0189	CcSEcCtD
Milnacipran—Angiopathy—Metformin—metabolic syndrome X	0.0153	0.0185	CcSEcCtD
Milnacipran—Mediastinal disorder—Metformin—metabolic syndrome X	0.0152	0.0184	CcSEcCtD
Milnacipran—Chills—Metformin—metabolic syndrome X	0.0152	0.0183	CcSEcCtD
Milnacipran—Malnutrition—Metformin—metabolic syndrome X	0.0147	0.0177	CcSEcCtD
Milnacipran—Flatulence—Metformin—metabolic syndrome X	0.0145	0.0175	CcSEcCtD
Milnacipran—Dysgeusia—Metformin—metabolic syndrome X	0.0144	0.0174	CcSEcCtD
Milnacipran—Vision blurred—Metformin—metabolic syndrome X	0.0139	0.0167	CcSEcCtD
Milnacipran—Tremor—Metformin—metabolic syndrome X	0.0138	0.0166	CcSEcCtD
Milnacipran—Syncope—Metformin—metabolic syndrome X	0.0132	0.0159	CcSEcCtD
Milnacipran—Palpitations—Metformin—metabolic syndrome X	0.013	0.0157	CcSEcCtD
Milnacipran—Loss of consciousness—Metformin—metabolic syndrome X	0.0129	0.0156	CcSEcCtD
Milnacipran—Hypertension—Metformin—metabolic syndrome X	0.0127	0.0153	CcSEcCtD
Milnacipran—Chest pain—Metformin—metabolic syndrome X	0.0125	0.0151	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.0124	0.015	CcSEcCtD
Milnacipran—Infection—Metformin—metabolic syndrome X	0.0119	0.0144	CcSEcCtD
Milnacipran—Shock—Metformin—metabolic syndrome X	0.0118	0.0142	CcSEcCtD
Milnacipran—Nervous system disorder—Metformin—metabolic syndrome X	0.0118	0.0142	CcSEcCtD
Milnacipran—Thrombocytopenia—Metformin—metabolic syndrome X	0.0118	0.0142	CcSEcCtD
Milnacipran—Skin disorder—Metformin—metabolic syndrome X	0.0117	0.0141	CcSEcCtD
Milnacipran—Hyperhidrosis—Metformin—metabolic syndrome X	0.0116	0.014	CcSEcCtD
Milnacipran—Anorexia—Metformin—metabolic syndrome X	0.0114	0.0138	CcSEcCtD
Milnacipran—Hypotension—Metformin—metabolic syndrome X	0.0112	0.0135	CcSEcCtD
Milnacipran—Paraesthesia—Metformin—metabolic syndrome X	0.0108	0.013	CcSEcCtD
Milnacipran—Dyspnoea—Metformin—metabolic syndrome X	0.0107	0.0129	CcSEcCtD
Milnacipran—Somnolence—Metformin—metabolic syndrome X	0.0107	0.0129	CcSEcCtD
Milnacipran—Dyspepsia—Metformin—metabolic syndrome X	0.0106	0.0127	CcSEcCtD
Milnacipran—Decreased appetite—Metformin—metabolic syndrome X	0.0104	0.0126	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.0104	0.0125	CcSEcCtD
Milnacipran—Fatigue—Metformin—metabolic syndrome X	0.0103	0.0125	CcSEcCtD
Milnacipran—Constipation—Metformin—metabolic syndrome X	0.0103	0.0124	CcSEcCtD
Milnacipran—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00982	0.0118	CcSEcCtD
Milnacipran—Urticaria—Metformin—metabolic syndrome X	0.00954	0.0115	CcSEcCtD
Milnacipran—Abdominal pain—Metformin—metabolic syndrome X	0.00949	0.0114	CcSEcCtD
Milnacipran—Asthenia—Metformin—metabolic syndrome X	0.00861	0.0104	CcSEcCtD
Milnacipran—Pruritus—Metformin—metabolic syndrome X	0.00849	0.0102	CcSEcCtD
Milnacipran—Diarrhoea—Metformin—metabolic syndrome X	0.00821	0.00991	CcSEcCtD
Milnacipran—Dizziness—Metformin—metabolic syndrome X	0.00794	0.00958	CcSEcCtD
Milnacipran—Vomiting—Metformin—metabolic syndrome X	0.00763	0.00921	CcSEcCtD
Milnacipran—Rash—Metformin—metabolic syndrome X	0.00757	0.00913	CcSEcCtD
Milnacipran—Dermatitis—Metformin—metabolic syndrome X	0.00756	0.00912	CcSEcCtD
Milnacipran—Headache—Metformin—metabolic syndrome X	0.00752	0.00907	CcSEcCtD
Milnacipran—Nausea—Metformin—metabolic syndrome X	0.00713	0.0086	CcSEcCtD
